Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Evening SS17,
You may be correct about someone taking this over but much more likely imo by a larger CRO like Covance and nit a big pharma as does nit really fit in with their core business.
I like this statement ; a tiny AiM co got so many big Pharma contract in the pipeline; now potential UK government! Current share price will be a history, very soon it will become a billion $ co or wouldn’t even be surprised if it’s taken over by a big Pharma giant like Astra or Pfizer or Gillead !!
“Open Orphan has become a cash-generating machine with Cathal Friel at the helm, stripping out costs and slimming down the executive team at the top. “
Indeed Barwickman
Might be still on , as I was asked to sign up if I wanted, but I know it could be pulled at any moment, out of interest GG what was your google close tonight, was it bang on again .
There is a presentation that CH is due to give on Tuesday. That is already known.
But there was also a tweet 2 weeks ago I think from Directors Talk which said they had a Interview with CF arranged lined up then but had cancelled it due to impending news and they would rearrange it.
I got the impression the news would be pretty good so would not be surprised if we heard something about a rearranged presentation next week.
Can someone drag up up the original tweet and remind ourselves
Ivyspivey ,can you please expand on your post please
Marko you sound a bit disappointed there lol
I guess a rise into close is to be expected if the RNS may drop on Monday confirming the government contract
TH Really nice find.
Looking forward to next week and presentation.
Plus any news on the Presentation that was due to be rearranged. Expect that soon